- Home
- ยป
- Our Products
- »
- Pharmaceutical Tablets - 2
Pharmaceutical Tablets - 2
Zonaxid Nitazoxanide 500mg Tablets
Product Brochure
| Strength | 500 mg |
| Packaging Size | 6 Tablets in 1 Strip |
| Composition | Nitazoxanide 500 mg |
| Brand | Zonaxid 500mg |
| Manufacturer | Macleods Pharmaceuticals Pvt Ltd |
| Usage/Applicat | Treatment of Diarrhea, Worm infections |
Introduction: Zonaxid contains Nitazoxanide, an antiparasitic and antiviral medication used to treat a variety of infections. It is effective against certain gastrointestinal infections caused by protozoa and helminths, as well as some viral infections.
Indications for Use:
- Protozoal Infections: Used for the treatment of infections such as giardiasis (caused by Giardia lamblia) and cryptosporidiosis (caused by Cryptosporidium parvum).
- Viral Infections: Indicated for the treatment of viral gastroenteritis, particularly in immunocompromised patients.
Mechanism of Action: Nitazoxanide works by inhibiting the anaerobic energy metabolism of protozoa and certain viruses, leading to their death. It disrupts the pyruvate-ferredoxin oxidoreductase (PFOR) enzyme-dependent electron transport, which is essential for energy production in these organisms.
Dosage and Administration:
- Dosage: The typical adult dose is 500 mg taken orally twice daily. Dosing may vary based on the specific infection and patient factors.
- Administration: Can be taken with or without food. It’s advisable to take it consistently at the same times each day.
Contraindications:
- Hypersensitivity: Known allergies to Nitazoxanide or any components of the formulation.
- Pregnancy and Breastfeeding: Use during pregnancy should be approached with caution; consult a healthcare provider.
Warnings and Precautions:
- Liver Function: Caution is advised in patients with liver disease; liver function tests may be recommended.
- Drug Interactions: Inform healthcare providers of all medications being taken, as Nitazoxanide may interact with other drugs.
Common Side Effects:
- Nausea
- Abdominal pain
- Diarrhea
- Headache
Serious Side Effects:
- Allergic reactions (rash, itching, swelling)
- Severe gastrointestinal symptoms
Storage Instructions: Store Zonaxid at room temperature, away from moisture and light. Follow any specific storage guidelines provided on the product label.
Patient Counseling Information:
- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects.
- Complete the Course: Emphasize the importance of completing the full course of treatment as prescribed.
Conclusion: Zonaxid (Nitazoxanide) 500 mg Tablets are an effective treatment option for various gastrointestinal infections. Proper usage and adherence to the treatment plan are essential for achieving the best outcomes. Always consult a healthcare professional for personalized advice and guidance regarding this medication.
Tenolam E Tablets Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) + Efavirenz (600mg)
Product Brochure
| Dose/Strength | 300mg/300mg/600mg |
| Composition | Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg + Efavirenz 600 mg |
| Packaging Size | 1x30Tablets |
| Strength | Lamivudine 300 mg, Tenofovir Disoproxil Fumarate 300 mg, Efavirenz 600 mg |
| Brand Name | Tenolam E Tablets |
| Manufacturer By | Hetero Helthcare |
| Treatment | HIV Infection |
Tenolam E Tablets (Lamivudine 300 mg, Tenofovir Disoproxil Fumarate 300 mg, Efavirenz 600 mg)
Overview: Tenolam E is a fixed-dose combination antiretroviral medication used for the treatment of HIV-1 infection. It combines lamivudine, tenofovir disoproxil fumarate, and efavirenz to provide a comprehensive approach to managing the virus.
Indications:
- HIV Infection: Indicated for the treatment of HIV-1 infection in adults and pediatric patients as part of a comprehensive antiretroviral regimen.
Mechanism of Action:
- Lamivudine: A nucleoside reverse transcriptase inhibitor (NRTI) that blocks reverse transcriptase, preventing the conversion of viral RNA into DNA.
- Tenofovir Disoproxil Fumarate: Another NRTI that inhibits reverse transcriptase, reducing viral replication.
- Efavirenz: A non-nucleoside reverse transcriptase inhibitor (NNRTI) that binds to reverse transcriptase and inhibits its activity, further preventing viral replication.
Dosage and Administration:
- Recommended Dose: Typically, one tablet taken orally once daily.
- Administration: Can be taken with or without food, but taking it on an empty stomach is generally recommended to minimize side effects.
Side Effects: Common side effects may include:
- Nausea
- Dizziness
- Fatigue
- Headache
- Rash
- Possible changes in mood or sleep disturbances (particularly with efavirenz)
Warnings and Precautions:
- CNS Effects: Efavirenz can cause central nervous system (CNS) side effects; caution is advised in patients with a history of mental health issues.
- Liver Function: Regular monitoring of liver function is advised, particularly in patients with a history of liver disease.
- Renal Function: Monitor kidney function, especially in patients receiving tenofovir.
Contraindications:
- Hypersensitivity to any of the components.
- Severe liver impairment.
Drug Interactions: Tenolam E may interact with other medications, particularly those that affect liver enzymes. It is important for patients to inform their healthcare provider about all medications and supplements being taken.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and not to miss doses.
- Discuss the importance of regular follow-up appointments for monitoring viral load and overall health.
- Instruct patients to report any unusual side effects, especially related to mood changes or severe skin reactions.
Tenolam E Tablets (Lamivudine, Tenofovir Disoproxil Fumarate, and Efavirenz) are an effective treatment option for managing HIV-1 infection. Proper adherence to dosing, monitoring for side effects, and patient education are essential for optimizing treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Itraconazole & Terbinafine Tablets ( Terbiface Plus Tablets)
Product Brochure
| Strength | 500 mg |
| Composition | Itraconazole & Terbinafine |
| Packaging Size | 10*1*4 Capsule |
| Brand Name | Terbiface Plus Tablets) |
| Manufactured By | Healing Pharma India Pvt Ltd |
| Usage/Application | Parasitic Skin Diseases |
Overview
Terbiface Plus combines itraconazole and terbinafine, two antifungal agents, used to treat various fungal infections. This combination targets a broad spectrum of fungi, making it effective for various dermatological and systemic conditions.
- Fungal Infections: Effective in treating:
- Dermatophyte infections (e.g., ringworm, athlete's foot)
- Onychomycosis (fungal nail infections)
- Systemic fungal infections (e.g., histoplasmosis, blastomycosis)
- Itraconazole: An azole antifungal that works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to cell death.
- Terbinafine: A squalene epoxidase inhibitor that also disrupts ergosterol synthesis but does so through a different pathway, making it effective against certain fungi, especially dermatophytes.
- Dosage: The specific dosage should be determined by a healthcare provider based on the type and severity of the infection. A common regimen may involve taking one tablet daily or as directed.
- Administration: Tablets should be taken orally, preferably with food to enhance absorption.
Common side effects may include:
- Nausea
- Abdominal pain
- Diarrhea
- Headache
- Rash
- Liver Function: Monitor liver function tests, as both itraconazole and terbinafine can affect liver enzymes.
- Drug Interactions: Caution is advised when used with other medications, especially those that affect liver metabolism.
- Heart Failure: Itraconazole can exacerbate heart failure; use with caution in patients with a history of cardiac issues.
- Hypersensitivity: Known allergies to itraconazole, terbinafine, or any components of the formulation.
- Severe Liver Disease: Contraindicated in patients with severe hepatic impairment.
Terbiface Plus may interact with:
- CYP450 Inhibitors/Inducers: Both antifungals can affect the metabolism of other drugs metabolized by the liver, requiring careful monitoring and possible dose adjustments.
- Other Antifungals: Increased risk of side effects when combined with other antifungal medications.
- Store Terbiface Plus at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients about the importance of completing the full course of treatment, even if symptoms improve.
- Advise them to report any signs of liver dysfunction (e.g., jaundice, dark urine) or severe allergic reactions.
- Discuss potential side effects and the importance of regular follow-ups.
Terbiface Plus (Itraconazole and Terbinafine Tablets) is an effective antifungal treatment for a range of fungal infections. Proper usage, monitoring for side effects, and patient education are essential for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
Imatinib Imatirel 400mg Tablet
Product Brochure
| Dose/Strength | 400 mg |
| Packaging Size | 10 Tablets |
| Packaging Type | Stripe |
| Brand Name | Imatirel 400mg |
| Manufacturer | Reliance Life Sciences |
| Treatment | Cancer |
Imatirel is a tyrosine kinase inhibitor primarily used to treat specific types of cancers. It targets the BCR-ABL fusion protein, which is instrumental in the growth of certain cancer cells. This medication is essential for patients diagnosed with conditions like chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).
IndicationsImatirel is indicated for the treatment of:
- Chronic Myeloid Leukemia (CML): Effective in the chronic phase.
- Acute Lymphoblastic Leukemia (ALL): Particularly in cases involving the Philadelphia chromosome.
- Gastrointestinal Stromal Tumors (GIST): For patients with unresectable or metastatic tumors.
- Dermatofibrosarcoma Protuberans (DFSP): And other tumors expressing PDGFR.
Imatinib works by inhibiting the BCR-ABL fusion protein, blocking the signaling pathways that promote cancer cell survival and proliferation. This targeted action helps in controlling tumor growth.
Dosage and Administration- Standard Dosage: The typical adult dosage is 400 mg once daily. Dosages may vary based on the cancer type and patient response.
- Administration: Imatirel can be taken with or without food. If gastrointestinal upset occurs, taking it with food may alleviate discomfort. Swallow the tablet whole with water for best results.
Imatirel should not be used in:
- Patients with hypersensitivity to imatinib or any of its components.
- Individuals with severe liver impairment.
- Fluid Retention: Monitor for signs of edema or congestive heart failure.
- Liver Function: Regular liver function tests are recommended to detect potential liver enzyme elevations.
- Myelosuppression: Blood counts should be monitored regularly due to the risk of neutropenia, anemia, or thrombocytopenia.
- Drug Interactions: Inform your healthcare provider about all medications you are taking, as imatinib can interact with various drugs.
Common Side Effects include:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Edema (swelling)
- Skin rash
Serious Side Effects may involve:
- Severe allergic reactions
- Liver toxicity (elevated liver enzymes)
- Heart failure
- Myelosuppression (low blood counts)
Imatinib may interact with other medications, particularly those that affect liver enzymes. Always inform your healthcare provider about any other drugs or supplements you are using.
Storage InstructionsStore Imatirel at room temperature (20°C to 25°C or 68°F to 77°F) in a dry place, away from moisture and light.
Patient Counseling Information- Advise patients to report any signs of fluid retention, severe fatigue, or signs of infection.
- Discuss the importance of regular blood tests to monitor liver function and blood counts.
- Inform patients about potential side effects and provide guidance on when to seek medical attention.
Imatirel (Imatinib) is a vital medication for managing specific cancers, requiring careful monitoring for side effects and interactions. Always consult a healthcare professional for personalized medical advice and treatment plans.
Sorafenib (Soratib 200mg Tablet)
Product Brochure
| Packaging Size | 30 Tablets |
| Strength | 200 mg |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Brand | Soratib |
| Composition | Sorafenib |
Sorafenib (Soratib 200mg Tablet)
Overview:
Soratib (Sorafenib 200mg Tablet) is an oral chemotherapy medication used to treat certain types of cancer. It is primarily indicated for the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and differentiated thyroid carcinoma. Sorafenib is a multi-kinase inhibitor that works by blocking the angiogenesis (growth of new blood vessels) and the signaling pathways involved in tumor growth and spread. By inhibiting multiple tyrosine kinases, Sorafenib helps slow tumor progression and reduces cancer cell proliferation.
Indications:
Soratib 200mg Tablets are indicated for:
- Renal Cell Carcinoma (RCC): In patients with advanced or metastatic RCC.
- Hepatocellular Carcinoma (HCC): For patients with advanced liver cancer.
- Differentiated Thyroid Cancer: For patients with progressive disease after radioactive iodine treatment.
Mechanism of Action:
Sorafenib inhibits multiple kinases, including those involved in angiogenesis (VEGF receptors), as well as other kinases related to tumor cell proliferation (Raf, B-RAF, VEGFR, PDGFR, c-kit). This dual action disrupts both the growth of blood vessels that supply the tumor and the signaling pathways that control tumor cell survival and division. Sorafenib helps reduce tumor growth by cutting off its blood supply and limiting the proliferation of cancer cells.
Dosage and Administration:
- Recommended Dose: The usual dose is 200 mg twice daily, taken with or without food.
- Administration: Swallow the tablet whole with a glass of water.
- Missed Dose: If a dose is missed, take it as soon as possible, but if it is close to the next dose, skip the missed dose. Do not take two doses at once.
Side Effects:
Common side effects include:
- Fatigue, diarrhea, rash, hand-foot syndrome, and hypertension.
Serious side effects may include: - Liver toxicity: Regular liver function tests are needed.
- Hemorrhage: Risk of bleeding, especially in patients with HCC.
- Cardiovascular issues: Hypertension and ischemic events.
Precautions:
- Liver Disease: Caution in patients with liver impairment as Sorafenib can cause liver toxicity.
- Hypertension: Monitor blood pressure regularly, especially in patients with HCC.
- Pregnancy: Contraindicated in pregnancy due to potential fetal harm.
Storage:
Store Soratib 200mg Tablets at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion:
Soratib 200mg Tablet (Sorafenib) is an effective treatment for several types of advanced cancers. By inhibiting tumor growth and angiogenesis, it helps slow cancer progression. Regular monitoring for side effects, especially liver function and blood pressure, is crucial for safe and effective use.
Pirfenidone Pulmofib 267 mg Tablets
Product Brochure
| Strength | 267 mg |
| Packaging Size | 10X10 Tablets |
| Brand | Pulmofib 267 mg |
| Manufactured By | Msn Laboratories Pvt Ltd |
| Composition | Pirfenidone 267 mg |
| Treatment | Idiopathic Pulmonary Fibrosis |
| Medicine brand | Pulmofib |
| Medicine form | Tablet |
| Medicine name | pirfenidone tablets ip |
| Medicine strength | 267 mg |
| Packaging size | 10 x 10 tablets |
| Packaging type | Box |
| Salt composition | Pirfenidone |
Tavin L Tablets
Product Brochure
| Dose/Strength | 300 mg |
| Packaging Size | 1x30Tablets |
| Packaging Type | Box |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Shelf Life | 24 Month |
| Usage / Application | Hospital |
Tavin L Tablets
Indications:Tavin L is indicated for:
- The treatment of HIV-1 infection in combination with other antiretroviral agents.
- It may also be used in patients with a history of prior antiretroviral therapy failure.
Tavin L is a combination medication that typically includes tenofovir disoproxil fumarate (TDF) and lamivudine (3TC).
- Tenofovir is a nucleotide reverse transcriptase inhibitor (NRTI) that works by inhibiting the reverse transcriptase enzyme, preventing viral replication.
- Lamivudine is also an NRTI that interferes with the viral RNA synthesis, further inhibiting viral replication.
- Dosage: The usual recommended dose is one tablet taken orally once daily. The specific dosage may vary based on the patient's medical history and response to treatment.
- Administration: Tavin L can be taken with or without food. It is important to adhere to the prescribed regimen for optimal effectiveness.
- Hypersensitivity to tenofovir, lamivudine, or any components of the formulation.
- Significant renal impairment (specific dosage adjustments may be necessary).
- Liver Disease: Caution is advised in patients with pre-existing liver disease or hepatitis B infection, as discontinuation may lead to hepatitis flare.
- Renal Impairment: Monitor kidney function regularly, as TDF can affect renal function.
- Bone Health: Long-term use of tenofovir may be associated with decreased bone mineral density.
Common side effects:
- Nausea
- Diarrhea
- Fatigue
- Headache
- Dizziness
Serious side effects:
- Lactic acidosis
- Hepatotoxicity
- Severe allergic reactions
- Renal toxicity
Tavin L may interact with other medications, particularly those affecting renal function or that are metabolized by the liver. Inform healthcare providers of all medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from moisture and light. Keep out of reach of children.
Patient Counseling Information:- Advise patients to take the medication exactly as prescribed and not to miss doses.
- Discuss potential side effects and the importance of regular follow-up appointments for monitoring.
- Encourage patients to report any signs of liver problems, such as jaundice, dark urine, or persistent abdominal pain.
Tavin L Tablets are an effective treatment option for HIV-1 infection, providing a combination of active agents that help control viral replication. Continuous communication with healthcare providers is essential for managing potential side effects and ensuring optimal treatment outcomes. Always consult a healthcare professional for personalized medical advice.
Rivaroxaban Xarelto 15 mg Tablets
Product Brochure
| Strength | 15 mg |
| Packaging Size | 14 tablets in 1 strip |
| Composition | Rivaroxaban 15 mg |
| Brand | Xarelto 15mg |
| Manufactured By | Bayer Zydus Pharma Pvt Ltd |
| Treatment | Treatment and prevention of Blood clots |
Active Ingredient: Rivaroxaban
Uses:
Xarelto is primarily used for:
- Prevention of Blood Clots: Used in patients after knee or hip replacement surgery to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Stroke Prevention: In patients with nonvalvular atrial fibrillation to reduce the risk of stroke and systemic embolism.
- Treatment of DVT and PE: For the treatment and prevention of recurrence.
Rivaroxaban is an oral anticoagulant that works as a direct Factor Xa inhibitor. By inhibiting Factor Xa, it prevents the conversion of prothrombin to thrombin, thereby reducing the formation of fibrin and preventing blood clots.
Dosage and Administration:- Typical Dosage: For most indications, the typical dose is 15 mg taken orally once daily. Specific dosing may vary based on the condition being treated and individual patient factors.
- Administration: It can be taken with or without food, but taking it with food may enhance absorption. It's important to take the medication consistently at the same time each day.
- Active Bleeding: Avoid use in patients with active bleeding or conditions that increase the risk of bleeding.
- Hypersensitivity: Avoid in individuals with known allergies to Rivaroxaban or its components.
- Severe Renal Impairment: Caution is advised in patients with significant kidney problems.
- Bleeding Risk: There is an increased risk of bleeding; patients should be monitored for signs of bleeding.
- Discontinuation: Stopping Rivaroxaban suddenly can increase the risk of thrombotic events; consult a healthcare provider before discontinuation.
- Liver Function: Caution in patients with liver disease; liver function tests may be necessary.
- Bleeding complications (e.g., nosebleeds, bleeding gums)
- Nausea
- Headache
- Dizziness
- Severe bleeding (e.g., gastrointestinal bleeding, intracranial hemorrhage)
- Allergic reactions (e.g., rash, itching)
- Liver dysfunction
Store Xarelto tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or signs of bleeding.
- Adherence: Emphasize the importance of taking the medication as prescribed and not missing doses.
- Avoid Certain Medications: Inform patients about potential drug interactions and the need to consult their healthcare provider before taking new medications.
Xarelto (Rivaroxaban) 15 mg Tablets are an effective oral anticoagulant for preventing and treating blood clots. Proper adherence to the treatment regimen and monitoring for side effects are crucial for ensuring safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
Rivaroxaban Xarelto 20mg Tablet
Product Brochure
| Strength | 20 mg |
| Packaging Size | 14 Tablet in 1 Box |
| Composition | Rivaroxaban 20 mg Tablet |
| Brand | Xarelto 20mg |
| Manufactured By | Bayer Zydus Pharma Pvt Ltd |
| Treatment | Treatment and prevention of Blood clots |
Active Ingredient: Rivaroxaban
Uses:
Xarelto is primarily indicated for:
- Prevention of Stroke: In patients with non-valvular atrial fibrillation.
- Treatment and Prevention of Deep Vein Thrombosis (DVT): Including the prevention of recurrent DVT and pulmonary embolism (PE).
- Prevention of DVT: In patients undergoing hip or knee replacement surgery.
Rivaroxaban is a direct factor Xa inhibitor that works by blocking the action of factor Xa, a key enzyme in the coagulation cascade. This inhibition prevents the conversion of prothrombin to thrombin, reducing thrombus formation and leading to anticoagulation.
Dosage and Administration:- Typical Dosage: The usual dose for non-valvular atrial fibrillation is 20 mg taken orally once daily. For DVT or PE treatment, the dosage may vary; initial doses may start higher and then transition to maintenance dosing.
- Administration: Take Xarelto with food to enhance absorption and minimize gastrointestinal side effects.
- Hypersensitivity: Avoid in individuals with known allergies to Rivaroxaban or any formulation components.
- Active Bleeding: Not recommended for patients with active bleeding or significant bleeding disorders.
- Severe Renal Impairment: Caution in patients with severe renal dysfunction (creatinine clearance less than 15 mL/min).
- Bleeding Risk: Monitor for signs of bleeding, including unusual bruising, blood in urine or stools, and prolonged bleeding from cuts.
- Liver Function: Use with caution in patients with hepatic impairment, as it may increase bleeding risk.
- Drug Interactions: Inform healthcare providers about all medications being taken, especially other anticoagulants, as Rivaroxaban can interact with numerous drugs.
- Bleeding (minor and major)
- Nausea
- Headache
- Dizziness
- Rash
- Severe bleeding (e.g., gastrointestinal bleeding, intracranial hemorrhage)
- Liver dysfunction (e.g., jaundice)
- Allergic reactions (e.g., rash, swelling, difficulty breathing)
Store Xarelto tablets at room temperature, away from moisture and light. Follow any specific storage instructions provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms, especially signs of bleeding.
- Adherence: Emphasize the importance of taking the medication as prescribed and not missing doses.
- Avoid High-Risk Activities: Caution patients to avoid activities that could increase the risk of bleeding or injury.
Xarelto (Rivaroxaban) 20 mg Tablets are effective for preventing and treating thromboembolic events. Proper adherence to the treatment regimen and monitoring for side effects are crucial for ensuring safety and effectiveness. Always consult a healthcare professional for personalized advice regarding this medication.
Twinaqt 50mg + 300mg Tablets
Product Brochure
| Strength | Dolutegravir (50 mg ) & Tenofovir Disoproxil Fumarate ( 300 mg ) |
| Packaging Size | 1x30 |
| Composition | Dolutegravir 50 mg, Lamivudine 300 mg |
| Brand Name | Twinaqt 50 mg/300 mg |
| Manufacturer By | Emcure Pharmaceuticals Ltd |
| Treatment | HIV Infection |
Twinaqt (Dolutegravir + Tenofovir Disoproxil Fumarate) 50 mg + 300 mg TabletsOverview: Twinaqt is a fixed-dose combination antiretroviral medication containing dolutegravir and tenofovir disoproxil fumarate, used for the treatment of HIV-1 infection. This combination therapy helps suppress viral replication and improves immune function.Indications:HIV Infection: Indicated for the treatment of HIV-1 infection in adults and pediatric patients as part of a comprehensive antiretroviral regimen.Mechanism of Action:Dolutegravir: An integrase strand transfer inhibitor (INSTI) that inhibits the integrase enzyme, preventing the integration of viral DNA into the host genome, thereby halting viral replication.Tenofovir Disoproxil Fumarate: A nucleoside reverse transcriptase inhibitor (NRTI) that inhibits reverse transcriptase, preventing the conversion of viral RNA into DNA.Dosage and Administration:Recommended Dose: Typically, one tablet taken orally once daily.Administration: Can be taken with or without food. Consistency in timing is important for optimal effectiveness.Side Effects: Common side effects may include:InsomniaHeadacheFatigueNauseaDiarrheaPotential changes in kidney functionWarnings and Precautions:Renal Function: Regular monitoring of kidney function is recommended, especially in patients with pre-existing kidney issues.Liver Function: Monitor liver function, particularly in patients with a history of liver disease.Hypersensitivity Reactions: Be alert for signs of serious allergic reactions.Contraindications:Hypersensitivity to dolutegravir, tenofovir, or any components of the formulation.Not recommended during pregnancy unless the benefits outweigh the risks.Drug Interactions: Twinaqt may interact with various medications, particularly those affecting liver enzymes. Patients should inform their healthcare provider about all medications and supplements being taken.Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.Patient Counseling Information:Advise patients to take the medication as prescribed and not to miss doses.Discuss the importance of regular follow-up appointments for monitoring HIV viral load and overall health.Instruct patients to report any unusual side effects, particularly those related to kidney function or severe allergic reactions.ConclusionTwinaqt (Dolutegravir + Tenofovir Disoproxil Fumarate) 50 mg + 300 mg Tablets are an effective treatment option for managing HIV-1 infection. Proper adherence to dosing, monitoring for side effects, and patient education are essential for optimizing treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Ambrisentan Tablets (Endobloc 5mg Tablet)
Product Brochure
| Strength | 5 mg |
| Packaging Size | 10 tablets in 1 strip |
| Composition | Ambrisentan 5 mg |
| Brand Name | Endobloc 5 Tablet |
| Manufactured By | Cipla Ltd |
| Usage/Application | Pneumonic blood vessel hypertension (PAH) |
Endobloc contains Ambrisentan, a medication used primarily to treat pulmonary arterial hypertension (PAH). It belongs to a class of drugs known as endothelin receptor antagonists.
Indications for UseEndobloc is indicated for:
- Pulmonary Arterial Hypertension (PAH): Used to improve exercise capacity and delay disease progression in patients with PAH, either alone or in combination with other therapies.
Ambrisentan works by:
- Blocking Endothelin Receptors: It selectively antagonizes endothelin-1 receptors, which are involved in vasoconstriction and increased blood pressure. By blocking these receptors, Ambrisentan promotes vasodilation, leading to reduced pulmonary arterial pressure.
- Dosage: The typical starting dose is 5 mg once daily, which may be increased to 10 mg based on patient response and tolerability.
- Administration: Taken orally, with or without food. It is important to take the medication at the same time each day for consistent effectiveness.
Endobloc is contraindicated in:
- Hypersensitivity: Known allergies to Ambrisentan or any components of the formulation.
- Pregnancy: Should not be used during pregnancy due to potential fetal harm; effective contraception is required for women of childbearing age.
- Liver Function: Regular monitoring of liver function is essential, as Ambrisentan can cause liver enzyme elevations.
- Anemia: Monitor hemoglobin levels, as some patients may experience anemia during treatment.
Common side effects may include:
- Peripheral edema (swelling of the limbs)
- Headache
- Flushing
- Nasal congestion
Serious adverse effects can include:
- Liver enzyme abnormalities
- Severe hypotension
- Pulmonary edema (rare)
Ambrisentan may interact with other medications that affect liver enzymes or blood pressure. It’s important to inform healthcare providers about all medications and supplements being taken.
Storage InstructionsStore Endobloc at room temperature, away from moisture and light. Follow any specific storage guidelines provided on the product label.
Patient Counseling Information- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms, especially signs of liver dysfunction (e.g., jaundice).
- Contraceptive Measures: Women of childbearing age should use effective contraception during treatment and for a time after discontinuation.
Endobloc (Ambrisentan) 5 mg Tablets are an important treatment option for managing pulmonary arterial hypertension. Proper usage, monitoring, and patient education are crucial for optimizing treatment outcomes and minimizing risks. Always consult a healthcare professional for personalized advice and management plans.
200mg Fibrodone Pirfenidone Tablet
Product Brochure
| Strength | 200 mg |
| Packaging Size | 10X10 Tablets |
| Brand | Fibrodone 200 mg |
| Manufactured By | Lupin Ltd |
| Composition | Pirfenidone 200 mg |
| Treatment | Idiopathic pulmonary fibrosis |
Fibrodone (Pirfenidone 200mg Tablets)
Overview:
Fibrodone (Pirfenidone) is an oral antifibrotic medication used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), a condition characterized by progressive scarring of the lung tissue, which leads to difficulty breathing. Pirfenidone works by reducing the formation of fibrosis in the lungs, slowing the progression of the disease and improving overall lung function. It has both anti-inflammatory and anti-fibrotic properties, and it may also help reduce oxidative stress, a key factor in the development of fibrosis.
Indications:
Fibrodone 200mg Tablets are indicated for:
- Idiopathic Pulmonary Fibrosis (IPF): To slow the progression of lung fibrosis and improve pulmonary function in patients with IPF.
Mechanism of Action:
Pirfenidone works through multiple mechanisms to reduce fibrosis and inflammation. It inhibits the production of transforming growth factor-beta (TGF-β), a key mediator of fibrotic processes. By modulating fibroblast proliferation and reducing collagen synthesis, Pirfenidone helps slow the formation of scar tissue in the lungs, which is a hallmark of IPF. It also has anti-inflammatory effects and reduces oxidative stress, further contributing to its protective role in lung tissue.
Dosage and Administration:
- Idiopathic Pulmonary Fibrosis (IPF):
The usual starting dose is 200mg three times daily with food. The dose may be gradually increased to 400mg three times daily depending on the patient's tolerance and clinical response. - Administration: Swallow the tablets whole with food to reduce the risk of gastrointestinal side effects. Do not crush or chew the tablets.
Side Effects:
Common side effects may include:
- Gastrointestinal symptoms: Nausea, diarrhea, loss of appetite, and fatigue.
- Liver function abnormalities: Liver enzyme levels (AST, ALT) may be elevated, requiring periodic monitoring.
- Skin reactions: Rash and photosensitivity may occur, so patients should avoid prolonged sun exposure.
Serious side effects include: - Liver toxicity: Hepatotoxicity is a known risk, and liver function should be regularly monitored.
- Pulmonary issues: Rarely, severe lung complications, such as acute exacerbations of IPF, may occur.
Precautions:
- Liver Function: Regular liver function tests (LFTs) are essential, especially during the first few months of treatment, due to the risk of hepatotoxicity.
- Photosensitivity: Patients are advised to avoid direct sunlight and wear sunscreen due to the increased risk of sunburn and skin reactions.
- Gastrointestinal effects: If significant nausea or diarrhea occurs, dose adjustments may be needed.
- Pregnancy and Breastfeeding: Pirfenidone is contraindicated during pregnancy and breastfeeding as it may harm the fetus or infant.
- Renal Impairment: Use with caution in patients with severe renal impairment, though dose adjustments may be required in such cases.
Storage:
Store Fibrodone tablets at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion:
Fibrodone (Pirfenidone 200mg Tablets) is a crucial medication for patients with idiopathic pulmonary fibrosis, helping to slow disease progression and improve lung function. While generally well tolerated, patients should be monitored for liver function abnormalities, gastrointestinal side effects, and skin reactions. Adherence to dosing and regular follow-up care is essential for the best treatment outcomes.
Apigat 2.5 mg Apixaban Tablet
Product Brochure
| Strength | 2.5 mg |
| Pack Type | 30 Tablets in 1 Bottle |
| Salt Composition | Apixaban 2.5 mg |
| Brand Name | Apigat 2.5 mg Tablet |
| Manufactured By | Natco Pharma Ltd |
| Treatment | Blood Clusters |
Overview: Apigat 2.5 contains Apixaban, an oral anticoagulant (blood thinner) that works by inhibiting Factor Xa, an enzyme crucial for blood clotting. Apixaban is used to prevent and treat various thromboembolic conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation (AF) and other clotting disorders.
Indications: Apigat 2.5mg Tablet is indicated for:
- Prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (AF).
- Treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Prophylaxis of DVT following hip or knee replacement surgery.
Mechanism of Action: Apixaban works by selectively inhibiting Factor Xa, an enzyme that plays a central role in the coagulation cascade. By inhibiting Factor Xa, Apixaban prevents the conversion of prothrombin to thrombin, thereby reducing the formation of fibrin and the clotting process.
Dosage and Administration:
- Atrial Fibrillation: The recommended dose is 5mg twice daily, but for patients with certain risk factors (e.g., elderly, renal impairment), the dose may be reduced to 2.5mg twice daily.
- DVT/PE treatment: Initial dose of 10mg twice daily for the first 7 days, followed by 5mg twice daily for maintenance.
- DVT/PE Prophylaxis: 2.5mg twice daily after surgery.
The tablets should be taken with or without food.
Side Effects: Common side effects include:
- Bleeding events: Easy bruising, nosebleeds, or bleeding gums.
- Gastrointestinal disturbances: Nausea, abdominal pain.
- Fatigue, headache, or dizziness.
Serious side effects may include:
- Severe bleeding (e.g., internal bleeding, hematuria, or gastrointestinal bleeding).
- Anemia, thrombocytopenia (low platelet count).
Precautions:
- Bleeding Risk: Apixaban increases the risk of bleeding, including intracranial hemorrhage or spinal hematoma. Use with caution in patients with a history of bleeding disorders.
- Renal and Hepatic Impairment: Adjust dosage in patients with renal or liver dysfunction.
- Pregnancy and Breastfeeding: Apixaban should not be used during pregnancy unless clearly necessary. It is not recommended during breastfeeding.
- Drug Interactions: Apixaban can interact with other anticoagulants, antiplatelet agents, or drugs that affect liver enzymes (CYP3A4 inhibitors or inducers).
Storage: Store at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion: Apigat 2.5 (Apixaban) Tablet is an effective oral anticoagulant for preventing and treating thromboembolic conditions, such as stroke prevention in atrial fibrillation, DVT, and PE. Due to its bleeding risk, it is important for patients to be monitored regularly, particularly for signs of bleeding. Proper usage under medical supervision is key to its safe and effective use.
Apigat 5 mg Apixaban Tablet
Product Brochure
| Strength | 5 mg |
| Pack Type | 30 Tablets in 1 Bottle |
| Salt Composition | Apixaban 5 mg |
| Brand Name | Apigat 5 Table |
| Manufactured By | Natco Pharma Ltd. |
| Treatment | Blood Clusters |
Overview:
Apigat 5 Tablet contains Apixaban, an oral anticoagulant used to reduce the risk of blood clots in conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). Apixaban works by inhibiting factor Xa, a key enzyme in the coagulation cascade, which prevents the conversion of prothrombin to thrombin, thereby reducing clot formation.
Indications:
Apigat 5 Tablet is indicated for:
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Prevention of DVT and PE recurrence in patients who have completed initial therapy.
Mechanism of Action:
Apixaban selectively inhibits factor Xa, an enzyme that plays a critical role in the blood coagulation process. By inhibiting factor Xa, Apixaban reduces thrombin generation and prevents the formation of fibrin clots, thereby reducing the risk of thromboembolic events such as stroke, DVT, and PE.
Dosage and Administration:
- Atrial fibrillation: 5 mg twice daily, unless the patient meets certain criteria (age ≥80 years, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL), in which case the dose may be reduced to 2.5 mg twice daily.
- DVT/PE treatment: Initially, 10 mg twice daily for the first 7 days, followed by 5 mg twice daily for long-term treatment.
- DVT/PE prevention (after initial treatment): 2.5 mg twice daily.
Tablets should be taken with or without food.
Side Effects:
Common side effects include:
- Bleeding: Bruising, nosebleeds, or bleeding gums.
- Gastrointestinal issues: Nausea, diarrhea, or indigestion.
- Fatigue and headache.
Serious side effects may include:
- Severe bleeding (e.g., gastrointestinal bleeding, intracranial hemorrhage).
- Hepatotoxicity: Elevated liver enzymes.
- Hypersensitivity reactions: Rash, swelling, or difficulty breathing.
Precautions:
- Bleeding risk: Apixaban increases the risk of bleeding, especially in patients with active bleeding or a history of bleeding disorders.
- Renal or hepatic impairment: Dose adjustment may be necessary for patients with significant kidney or liver disease.
- Pregnancy: Not recommended during pregnancy unless absolutely necessary, as safety has not been established.
- Concomitant medications: Careful monitoring is required if used with other anticoagulants or drugs that affect bleeding risk.
Storage:
Store at room temperature (20°C–25°C) in a tightly closed container, away from moisture and light.
Conclusion:
Apigat 5 (Apixaban) Tablet is a potent anticoagulant used to prevent and treat thromboembolic events such as stroke, DVT, and PE. It offers a convenient, oral alternative to traditional anticoagulants and requires careful monitoring for bleeding risks, especially in patients with renal or hepatic impairment.
Piracetam And Citicoline (Strocit Plus Tablet)
Product Brochure
| Strength | 500mg/800mg |
| Pack Size | 5*10 Tablet |
| Composition | Citicoline 500mg + Piracetam 800mg |
| Brand Name | Strocit Plus Tablet |
| Manufactured By | Sun Pharmaceutical Industries Ltd |
| Usage/Application | Rehabilitation of Stroke |
Overview
Strocit Plus is a combination medication that contains piracetam and citicoline. It is used to enhance cognitive function and support brain health.
- Cognitive Impairment: Used in the management of cognitive dysfunction, including conditions like dementia, stroke recovery, and other neurological disorders.
- Memory Enhancement: Aimed at improving memory, attention, and learning abilities.
- Piracetam: A nootropic agent that enhances cognitive function by improving neuronal metabolism and increasing blood flow to the brain. It modulates neurotransmitter activity, particularly acetylcholine.
- Citicoline: A precursor to phosphatidylcholine, it supports the synthesis of phospholipids in cell membranes and helps in the repair and maintenance of neurons. It also enhances dopamine receptor sensitivity and promotes overall brain health.
- Dosage: The typical dosage is one tablet taken 1-2 times daily, or as directed by a healthcare provider. The dosage may vary based on individual needs and response.
- Administration: Tablets should be taken orally, with or without food. It’s important to follow the prescribed regimen.
Common side effects may include:
- Nausea
- Headache
- Insomnia
- Gastrointestinal disturbances
- Seizure Disorders: Use with caution in patients with a history of seizures; monitor closely for any adverse effects.
- Pregnancy and Lactation: Safety during pregnancy and breastfeeding has not been established; consult a healthcare provider before use.
- Hypersensitivity: Known allergies to piracetam, citicoline, or any components of the formulation.
- Severe Renal Impairment: Caution is advised in patients with significant renal dysfunction.
Strocit Plus may interact with:
- Anticoagulants: Caution in patients taking blood thinners, as citicoline may enhance their effects.
- Other Nootropics: Monitor for additive effects when used with other cognitive enhancers.
- Store Strocit Plus at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adherence to the prescribed regimen for optimal cognitive benefits.
- Advise them to report any unusual symptoms, especially gastrointestinal issues or changes in mental status.
Strocit Plus (Piracetam and Citicoline Tablet) is a valuable option for supporting cognitive function and brain health. Proper usage, monitoring for side effects, and patient education are essential for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
Zurig 80mg Tablet
Product Brochure
| Strength | 80mg |
| Packaging Size | 30 Tablets |
| Composition | Febuxostat 80mg |
| Brand Name | Zurig 80 mg |
| Manufactured | Zydus Cadila |
| Treatment | Gout |
Overview
Zurig contains febuxostat, a medication primarily used to manage hyperuricemia (high levels of uric acid) in patients with gout.
- Chronic Gout: Used to lower uric acid levels in adults with gout to prevent gout attacks and associated complications.
Febuxostat works by:
- Inhibiting Xanthine Oxidase: It blocks the enzyme xanthine oxidase, which is involved in the production of uric acid, thereby reducing uric acid levels in the blood.
- Dosage: The usual starting dose is 40 mg once daily, which can be increased to 80 mg based on uric acid levels and clinical response.
- Administration: Tablets can be taken with or without food, but should be taken at the same time each day for consistency.
Common side effects may include:
- Nausea
- Liver enzyme elevation
- Rash
- Gout flares during the initial treatment phase
- Hepatic Function: Regular monitoring of liver function is recommended, as febuxostat can cause elevated liver enzymes.
- Gout Flares: Patients may experience gout flares when starting treatment; prophylactic treatment with anti-inflammatory medications may be necessary during the initial therapy phase.
- Cardiovascular Risk: Patients with a history of cardiovascular disease should be monitored closely, as there have been reports of increased cardiovascular events.
- Hypersensitivity: Known allergies to febuxostat or any components of the formulation.
- Severe Liver Disease: Not recommended for patients with significant liver impairment.
Febuxostat may interact with:
- Theophylline: Monitoring may be necessary as febuxostat can increase the levels of theophylline.
- Antineoplastic Agents: Caution is advised with medications that can affect liver function or uric acid levels.
- Store Zurig at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed dosing regimen and the need for regular follow-ups to monitor uric acid levels.
- Advise them to report any signs of rash, liver issues, or worsening gout symptoms.
Zurig (80 mg Tablet) is an effective option for managing hyperuricemia in patients with gout. Proper administration, monitoring for side effects, and patient education are essential for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized advice and guidance.
Zurig Febuxostat 40 Mg Tablets
Product Brochure
| Strength | 40mg |
| Manufacturer | Zydus Cadila |
| Packaging Size | 1*2*15 Tablets |
| Composition | Febuxostat 40mg |
| Brand Name | Zurig |
| Treatment | Severe Gout, prevention of gout attacks. |
Overview
Zurig contains febuxostat, a medication used primarily for the management of hyperuricemia (high uric acid levels) in patients with gout.
- Chronic Gout: Indicated for the reduction of uric acid levels in adults with gout to prevent gout flares and related complications.
Febuxostat works by:
- Inhibiting Xanthine Oxidase: It blocks the enzyme xanthine oxidase, which plays a key role in the production of uric acid, thus lowering uric acid levels in the blood.
- Dosage: The usual starting dose is 40 mg once daily, which may be increased to 80 mg based on the patient's uric acid levels and clinical response.
- Administration: Tablets can be taken with or without food. Consistency in timing is important for optimal results.
Common side effects may include:
- Nausea
- Liver enzyme elevations
- Rash
- Gout flares upon initiation of therapy
- Hepatic Function: Regular monitoring of liver function tests is recommended, as febuxostat can cause liver enzyme elevations.
- Gout Flares: Initial treatment may trigger gout flares; prophylactic anti-inflammatory treatment may be necessary during this period.
- Cardiovascular Risk: Monitor patients with a history of cardiovascular disease, as there may be an increased risk of cardiovascular events.
- Hypersensitivity: Known allergies to febuxostat or any components of the formulation.
- Severe Liver Disease: Not recommended for use in patients with significant liver impairment.
Febuxostat may interact with:
- Theophylline: Monitoring may be required as febuxostat can increase the levels of theophylline.
- Other Medications: Caution with drugs that may affect liver function or uric acid levels.
- Store Zurig at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed dosage and attending regular follow-ups to monitor uric acid levels.
- Advise them to report any severe side effects, including signs of liver dysfunction or worsening gout symptoms.
Zurig (Febuxostat 40 mg Tablets) is an effective treatment for managing hyperuricemia in patients with gout. Proper usage, monitoring for side effects, and patient education are essential for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
Desogestrel And Ethinyl Estradiol Tablets(Noveheal Tablet)
Product Brochure
| Packaging Size | 21 Tablets |
| Composition | Desogestrel And Ethinyl Estradiol |
| Brand Name | Noveheal Tablet |
| Manufactured By | Aquwell Pharma Pvt Ltd |
| Usage | Help with discomfort |
Overview
Noveheal is a combination oral contraceptive that contains desogestrel and ethinyl estradiol. It is primarily used for the prevention of pregnancy.
- Contraception: Used for the prevention of pregnancy in women of reproductive age.
The combination of desogestrel and ethinyl estradiol works through several mechanisms:
- Inhibition of Ovulation: Suppresses ovulation by preventing the release of eggs from the ovaries.
- Thickening of Cervical Mucus: Increases the viscosity of cervical mucus, making it more difficult for sperm to enter the uterus.
- Alteration of the Endometrial Lining: Changes the lining of the uterus, making it less suitable for implantation.
- Dosage: Take one tablet daily, at the same time each day, for 21 days followed by a 7-day pill-free interval, during which withdrawal bleeding usually occurs.
- Administration: Tablets can be taken with or without food. It's important to follow the prescribed regimen for maximum effectiveness.
Common side effects may include:
- Nausea
- Headache
- Breast tenderness
- Mood changes
- Weight gain
- Cardiovascular Risk: May increase the risk of thromboembolic events (blood clots), particularly in women with risk factors (smoking, obesity, etc.).
- Liver Disease: Should be used with caution in women with liver disease or liver tumors.
- Hormonal Effects: Monitor for signs of hormonal side effects, such as mood changes or breast tenderness.
- Pregnancy: Should not be used during pregnancy.
- History of Thromboembolic Disorders: Contraindicated in women with a history of blood clots or stroke.
- Liver Disorders: Known liver tumors or significant liver disease.
Noveheal may interact with:
- Antibiotics: Some antibiotics may reduce the effectiveness of hormonal contraceptives.
- Antiepileptic Drugs: Certain medications for epilepsy can decrease the effectiveness of the pill.
- Store Noveheal at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients about the importance of taking the tablet at the same time every day for maximum effectiveness.
- Advise them to report any unusual side effects, especially signs of blood clots (e.g., swelling, pain in the legs, sudden chest pain).
- Discuss the importance of using additional contraceptive methods during the first month of use if switching from another contraceptive method.
Noveheal (Desogestrel and Ethinyl Estradiol Tablets) is an effective oral contraceptive option for pregnancy prevention. Proper usage, monitoring for side effects, and patient education are crucial for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
Torsemide Spironolactone Tablets (Torseheal Plus 10mg Tablets)
Product Brochure
| Dose/Strength | 10 mg |
| Pack Size | 10 Tablats in 1 sripe |
| Composition | Spironolactone 50mg & Torasemide 10mg |
| Brand Name | Torseheal Plus 10mg Tablets |
| Manufacturer | Healing Pharma India Pvt Ltd |
| Usage | Treatment of Edema |
Overview
Torseheal Plus combines torsemide, a loop diuretic, and spironolactone, a potassium-sparing diuretic. This combination is used to manage conditions associated with fluid retention (edema) and hypertension.
- Edema: Used for the treatment of edema associated with congestive heart failure, liver cirrhosis, or renal disorders.
- Hypertension: Effective in managing high blood pressure, often as part of a broader antihypertensive regimen.
- Torsemide: Inhibits sodium and chloride reabsorption in the loop of Henle in the kidneys, leading to increased urine production and reduction of fluid overload.
- Spironolactone: Acts as an aldosterone antagonist, promoting sodium excretion while conserving potassium, which helps maintain electrolyte balance.
- Dosage: The typical starting dose is 10 mg, which may be adjusted based on the patient's response and clinical condition. Follow the healthcare provider’s instructions for specific dosing.
- Administration: Take the tablets orally, preferably at the same time each day. Can be taken with or without food.
Common side effects may include:
- Electrolyte imbalances (e.g., hyperkalemia)
- Dizziness
- Fatigue
- Nausea
- Increased urination
- Electrolyte Monitoring: Regular monitoring of electrolytes (especially potassium) and renal function is essential to prevent complications.
- Caution in Renal Impairment: Use with caution in patients with renal impairment; dosage adjustments may be necessary.
- Hypotension Risk: Monitor for signs of low blood pressure, particularly when starting treatment or adjusting dosages.
- Anuria: Contraindicated in patients with anuria (absence of urine production).
- Hypersensitivity: Known allergies to torsemide, spironolactone, or any components of the formulation.
- Severe Hyperkalemia: Should not be used in patients with significantly elevated potassium levels.
Torseheal Plus may interact with:
- Other Diuretics: May enhance the effects of other diuretics, increasing the risk of dehydration and electrolyte imbalance.
- ACE Inhibitors and ARBs: Use with caution due to the potential for increased potassium levels.
- Store Torseheal Plus at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed regimen and attending regular follow-up appointments for monitoring.
- Advise them to report any signs of electrolyte imbalances, such as muscle cramps, irregular heartbeat, or fatigue.
- Encourage lifestyle modifications, including dietary changes (e.g., potassium restriction if necessary) and fluid management.
Torseheal Plus (Torsemide and Spironolactone Tablets) is an effective treatment for managing fluid retention and hypertension. Proper usage, monitoring for side effects, and patient education are crucial for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
Febuxostat Tablets (Febutop 40mg Tablets)
Product Brochure
| Strength | 40mg |
| Manufacturer | Healing Pharma India Pvt Ltd |
| Packaging Size | 3*10 Tablets |
| Composition | Febuxostat 40mg |
| Brand Name | Febutop 40mg Tablet |
| Treatment | Gout |
Overview
Febutop contains febuxostat, a medication used primarily to manage hyperuricemia (high uric acid levels) in patients with gout.
- Gout Management: Used for the chronic management of gout to lower uric acid levels in patients with a history of gout attacks.
Febuxostat works by:
- Inhibiting Xanthine Oxidase: It blocks the action of xanthine oxidase, an enzyme involved in the production of uric acid. This leads to decreased levels of uric acid in the blood, helping to prevent gout attacks.
- Dosage: The typical starting dose is 40 mg once daily, which may be increased to 80 mg once daily based on uric acid levels and clinical response.
- Administration: Can be taken with or without food. It’s important to follow the prescribed dosage regimen.
Common side effects may include:
- Nausea
- Liver function abnormalities
- Rash
- Headache
- Gout flares (initially)
- Gout Flares: Patients may experience an increase in gout flares during the initial treatment period; prophylactic treatment with anti-inflammatory medications may be recommended.
- Liver Function: Regular monitoring of liver function tests is advised, as febuxostat can cause elevated liver enzymes.
- Cardiovascular Risk: Use with caution in patients with a history of cardiovascular disease; discuss potential risks with a healthcare provider.
- Hypersensitivity: Known allergies to febuxostat or any components of the formulation.
- Severe Liver Impairment: Not recommended for use in patients with severe liver dysfunction.
Febuxostat may interact with:
- Theophylline: Caution is advised when used concurrently, as febuxostat can increase theophylline levels.
- Anticoagulants: Monitor patients taking anticoagulants, as interactions may occur.
- Store Febutop at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adherence to the prescribed regimen for effective management of gout.
- Advise them to report any unusual symptoms, especially skin rashes, signs of liver dysfunction, or increased gout flares.
- Encourage patients to maintain a healthy lifestyle, including hydration and dietary modifications.
Febutop (Febuxostat 40 mg Tablets) is an effective treatment for managing hyperuricemia in gout patients. Proper usage, monitoring for side effects, and patient education are essential for achieving optimal outcomes. Always consult a healthcare provider for personalized advice and guidance.
Valgan Valganciclovir 450 Mg
Product Brochure
| Packaging Size | 1*4 Tablets |
| Dose/Strength | 450 mg |
| Pack size | 4 Tablet |
| Composition (salt) | Valganciclovir 450 mg |
| Brand Name | Valgan 450 mg |
| Manufactured By | Cipla Ltd |
| Usage/Application | Cytomegalovirus Infection |
Overview
Valgan contains valganciclovir, an antiviral medication used primarily for the prevention and treatment of cytomegalovirus (CMV) infections, particularly in immunocompromised patients.
- CMV Retinitis: Used in patients with acquired immunodeficiency syndrome (AIDS) who have CMV retinitis.
- Prevention of CMV Infection: Used for the prevention of CMV disease in kidney transplant recipients and other high-risk patients.
Valganciclovir is a prodrug that is converted in the body to ganciclovir, which works by:
- Inhibiting Viral DNA Synthesis: It interferes with the replication of viral DNA, thereby inhibiting the growth of the virus.
- Dosage: The typical dose for treating CMV retinitis in adults is 900 mg taken twice daily for 21 days, followed by 900 mg once daily for maintenance. For prevention in transplant patients, the usual dose is 900 mg once daily.
- Administration: Tablets should be taken orally with food to enhance absorption. Ensure adequate hydration.
Common side effects may include:
- Diarrhea
- Nausea
- Vomiting
- Fatigue
- Bone marrow suppression (leading to anemia, leukopenia, or thrombocytopenia)
- Hematologic Effects: Regular monitoring of blood counts is essential due to the risk of bone marrow suppression.
- Renal Function: Monitor renal function, as valganciclovir is eliminated primarily through the kidneys.
- Teratogenic Effects: Valganciclovir can cause birth defects; effective contraception is crucial for both men and women during treatment.
- Hypersensitivity: Known allergies to valganciclovir, ganciclovir, or any components of the formulation.
- Severe Bone Marrow Suppression: Contraindicated in patients with a history of severe neutropenia or thrombocytopenia.
Valganciclovir may interact with:
- Other Antivirals: Caution is advised when used with other medications that may also cause bone marrow suppression.
- Renal Drugs: Medications that affect renal function may alter the clearance of valganciclovir.
- Store Valgan at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed regimen and the necessity of regular blood monitoring.
- Advise them to report any signs of infection, unusual bleeding, or other severe side effects immediately.
Valgan (Valganciclovir 450 mg Tablets) is an important antiviral medication for managing and preventing CMV infections, particularly in high-risk populations. Proper administration, monitoring for side effects, and patient education are vital for effective treatment outcomes. Always consult a healthcare provider for personalized advice and guidance.
Alpha Ketoanalogue Ketosteril Tablet
Product Brochure
| Packaging Size | 5*20 Tablets |
| Pack Size | 10 Tablet |
| Composition | Alpha Ketoanalogue (NA) |
| Brand Name | Ketosteril Tablet |
| Manufacturer | Fresenius Kabi India Pvt Ltd |
| Treatment | Chronic kidney disease |
Overview
Ketosteril is a dietary supplement that contains a combination of alpha-keto acids, which are used to manage patients with chronic kidney disease (CKD), particularly those on a protein-restricted diet.
- Chronic Kidney Disease: Used as a supplement in patients with CKD to help manage protein intake while ensuring adequate nutrition and minimizing nitrogenous waste buildup.
Alpha-keto acids are precursors to essential amino acids and can help:
- Reduce Protein Catabolism: They provide a non-protein source of nitrogen for amino acid synthesis, helping to maintain protein balance without increasing urea levels.
- Dosage: The typical dosage is determined by a healthcare provider based on individual dietary needs and renal function. It is generally taken with meals to enhance absorption.
- Administration: Tablets should be taken orally, as directed by a healthcare professional.
Common side effects may include:
- Gastrointestinal disturbances (nausea, diarrhea)
- Allergic reactions (rare)
- Monitoring: Regular monitoring of renal function and nutritional status is essential to adjust dosages and dietary intake as needed.
- Dietary Adjustments: Patients should follow a protein-restricted diet as advised by their healthcare provider to maximize the benefits of Ketosteril.
- Hypersensitivity: Known allergies to any components of the formulation.
- Acute Kidney Injury: Not recommended in patients with acute renal failure.
Ketosteril generally has a low potential for drug interactions, but it's always important to inform healthcare providers about all medications and supplements being taken.
Storage Instructions- Store Ketosteril at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to their prescribed dietary restrictions and the role of Ketosteril in their overall management.
- Advise them to report any unusual symptoms, particularly gastrointestinal issues or allergic reactions.
Ketosteril (Alpha Ketoanalogue Tablets) is a useful dietary supplement for managing chronic kidney disease by providing essential amino acids without increasing protein intake. Proper usage, monitoring, and patient education are key to achieving effective outcomes. Always consult a healthcare provider for personalized advice and guidance.
Zyloric 300 mg Tablet
Product Brochure
| Strength | 300 mg |
| Packaging Size | 10* 10 Tablets |
| Composition | Allopurinol 300mg |
| Brand Name | Zyloric 300 mg |
| Manufacturer | Glaxo SmithKline Pharmaceuticals Ltd |
| Treatment | Treat Gout |
Overview
Zyloric contains allopurinol, a medication used to lower uric acid levels in the blood, primarily for the management of gout and certain types of kidney stones.
- Chronic Gout: Used for the long-term management of hyperuricemia associated with gout to prevent gout attacks.
- Hyperuricemia: Management of hyperuricemia in patients receiving chemotherapy or radiation therapy for certain cancers, which can lead to increased uric acid levels.
Allopurinol works by:
- Inhibiting Xanthine Oxidase: It reduces the production of uric acid by inhibiting the enzyme xanthine oxidase, which converts hypoxanthine and xanthine into uric acid.
- Dosage: The usual starting dose is 100 to 300 mg per day, depending on the severity of hyperuricemia and clinical response. Dosage can be adjusted based on uric acid levels.
- Administration: Tablets should be taken orally, preferably after meals, to minimize gastrointestinal irritation. Adequate hydration is important to reduce the risk of kidney stones.
Common side effects may include:
- Rash
- Nausea
- Diarrhea
- Liver enzyme elevation
- Rarely, hypersensitivity reactions (such as Stevens-Johnson syndrome)
- Skin Reactions: Monitor for skin rash, especially during the first few weeks of treatment; discontinue use if severe rash occurs.
- Hepatic Function: Regular monitoring of liver function tests is recommended.
- Kidney Function: Assess renal function before starting treatment and adjust dosage as necessary.
- Hypersensitivity: Known allergies to allopurinol or any components of the formulation.
- Acute Gout Attacks: Not recommended during acute gout flares; treatment should begin after the attack has resolved.
Allopurinol may interact with:
- Azathioprine and Mercaptopurine: Increased toxicity; dosage adjustment may be necessary.
- Warfarin: May enhance the anticoagulant effect; monitor INR closely.
- Store Zyloric at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adherence to the prescribed regimen and the need for regular follow-ups to monitor uric acid levels.
- Advise them to maintain adequate fluid intake and report any skin rashes, gastrointestinal issues, or signs of liver dysfunction.
Zyloric (Allopurinol 300 mg Tablets) is an effective option for managing hyperuricemia in patients with gout and certain cancer treatments. Proper administration, monitoring for side effects, and patient education are crucial for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized advice and guidance.
1mg Baraclude Entecavir Tablets
Product Brochure
| Strength | 1 mg |
| Packaging Size | 30 Tablets in 1 Bottle |
| Composition | Entecavir 1mg |
| Brand Name | Baraclude |
| Prescription/Non prescription | Prescription |
| Manufacturer | BMS India Pvt Ltd |
| Usages | Chronic hepatitis B virus infection |
| Also gives | Third Party Manufacturing |
| Packaging Type | Bottles |
| Country of Origin | Made in India |
Description:
Entecavir is an antiviral medication that is primarily used to treat chronic hepatitis B virus (HBV) infection. It works by inhibiting the replication of the virus, thereby reducing the amount of HBV in the body and improving liver function.
Indications:
Entecavir is indicated for the treatment of:
- Chronic Hepatitis B Virus Infection: Effective in adults and children aged 2 years and older with active liver disease.
Dosage and Administration:
- Dosage: The recommended dose for adults is typically 0.5 mg once daily for those without previous treatment, and 1 mg once daily for those who have previously been treated with other antiviral therapies. Pediatric dosing may vary based on weight.
- Administration: Taken orally, with or without food. It is important to take entecavir at the same time each day to maintain consistent blood levels.
Common Side Effects:
- Fatigue
- Headache
- Dizziness
- Nausea
- Diarrhea
Precautions:
- Liver Function Monitoring: Regular liver function tests are essential, as reactivation of hepatitis B can occur after stopping treatment.
- Renal Impairment: Dose adjustments may be necessary for patients with kidney problems.
- Not Recommended During Pregnancy: Consult a healthcare provider for risk assessment and alternative options.
Conclusion:
Entecavir (Baraclude 1 mg) is an antiviral medication used to treat chronic hepatitis B infection. Treatment should be closely monitored by a healthcare professional to ensure safety and effectiveness, with regular assessments of liver function and potential side effects.
Hisone 10mg Tablet
Product Brochure
| Strength | 10mg |
| Packaging Size | 20*10 Tablets |
| Manufacturer | Samarth Life Sciences Pvt. Ltd |
| Composition | Hydrocortisone 10 mg |
| Brand Name | Hisone 10 mg |
| Treatment | Severe Allergic Reactions |
Active Ingredient: Hydrocortisone
Uses:
Hisone is primarily indicated for:
- Adrenal Insufficiency: Replacement therapy in conditions like Addison's disease.
- Inflammatory Conditions: Treatment of conditions such as asthma, arthritis, and allergic reactions.
- Autoimmune Disorders: Management of diseases like lupus and multiple sclerosis.
Hydrocortisone is a corticosteroid that works by mimicking the effects of cortisol, a hormone produced by the adrenal glands. It has anti-inflammatory, immunosuppressive, and anti-allergic properties, helping to reduce inflammation and suppress the immune response.
Dosage and Administration:- Typical Dosage: The dosage varies based on the condition being treated. For adrenal insufficiency, it may range from 10 mg to 30 mg daily, divided into two or three doses.
- Administration: Take the tablets with food to reduce gastrointestinal irritation. Consistent timing helps maintain stable hormone levels.
- Hypersensitivity: Avoid in individuals with known allergies to Hydrocortisone or any components of the formulation.
- Systemic Fungal Infections: Not recommended in patients with systemic fungal infections.
- Infections: Caution in patients with infections, as corticosteroids can mask symptoms.
- Gastrointestinal Issues: Monitor for peptic ulcers or gastrointestinal bleeding.
- Osteoporosis: Long-term use may increase the risk of osteoporosis; consider preventive measures.
- Weight gain
- Mood changes
- Increased appetite
- Insomnia
- Fluid retention
- Severe allergic reactions (e.g., rash, swelling, difficulty breathing)
- Symptoms of adrenal insufficiency (e.g., fatigue, dizziness)
- Increased blood sugar levels (hyperglycemia)
Store Hisone tablets at room temperature, away from moisture and light. Follow any specific storage instructions provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms, especially severe mood changes or signs of infection.
- Adherence: Emphasize the importance of taking the medication as prescribed and not abruptly stopping without consulting a healthcare provider.
- Lifestyle Modifications: Encourage a balanced diet and regular exercise to manage weight gain and other side effects.
Hisone (Hydrocortisone) 10 mg Tablets are effective for managing a variety of conditions related to adrenal insufficiency and inflammation. Proper adherence to the treatment regimen and monitoring for side effects are essential for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
Efavirenz Tablets ( Efavir 600 mg Tablets)
Product Brochure
| Dose/Strength | 600 mg |
| Packaging Size | 1x30 Tablets |
| Composition | Efavirenz 600 mg |
| Brand Name | Efavir 600 mg |
| Manufacturer By | Cipla Ltd |
| Treatment | Ongoing Hepatitis B Infection (HBV) Contamination |
Efavir (Efavirenz) 600 mg Tablets
Overview: Efavir is a brand name for efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infection. It is typically prescribed as part of a combination antiretroviral therapy.
Indications:
- HIV Infection: Indicated for the treatment of HIV-1 infection in adults and pediatric patients aged 3 months and older, as part of a complete antiretroviral regimen.
Mechanism of Action: Efavirenz works by binding to the reverse transcriptase enzyme, causing a change in its structure that inhibits its function. This prevents the conversion of viral RNA into DNA, thereby limiting the replication of the virus.
Dosage and Administration:
- Recommended Dose: The usual adult dose is 600 mg taken orally once daily, preferably at bedtime to minimize central nervous system side effects.
- Administration: Can be taken with or without food, but should be taken consistently at the same time each day.
Side Effects: Common side effects may include:
- Dizziness
- Drowsiness
- Rash
- Nausea
- Fatigue
- Possible neuropsychiatric effects (e.g., depression, anxiety)
Warnings and Precautions:
- Neuropsychiatric Symptoms: Efavirenz may cause serious psychiatric symptoms in some patients; monitor for any mood changes or unusual behavior.
- Hepatic Function: Use with caution in patients with a history of liver disease; liver function tests should be performed regularly.
- Pregnancy: Should be used with caution in pregnant women, especially in the first trimester, due to potential risks to the fetus.
Contraindications:
- Hypersensitivity to efavirenz or any components of the formulation.
- Concomitant use with certain medications that may cause significant interactions.
Drug Interactions: Efavirenz may interact with a variety of medications, especially those metabolized by the liver. Patients should inform their healthcare provider about all medications, including over-the-counter drugs and supplements.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and not to miss doses for optimal effectiveness.
- Discuss the importance of regular follow-up appointments for monitoring health and viral load.
- Instruct patients to report any unusual side effects, particularly neuropsychiatric symptoms or skin reactions.
Efavir (Efavirenz) 600 mg Tablets are an effective component of HIV-1 treatment regimens. Adherence to the prescribed regimen, monitoring for side effects, and patient education are essential for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Baraclude Entecavir 0.5 mg Tablets
Product Brochure
| Strength | 0.5 mg |
| Packaging Size | 30 Tablets in 1 Box |
| Composition | Entecavir 0.5 mg |
| Brand | Baraclude 0.5 mg |
| Manufactured By | BMS India Pvt Ltd |
| Usages/Application | Chronic Hepatitis B Virus (HBV) Infectio |
Baraclude (Entecavir) 0.5 mg Tablets
Overview: Baraclude is a brand name for entecavir, an antiviral medication used primarily for the treatment of chronic hepatitis B virus (HBV) infection. It helps reduce viral load and improve liver function in affected individuals.
Indications:
- Chronic Hepatitis B Infection: Indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients over 2 years of age who have evidence of active viral replication.
Mechanism of Action: Entecavir is a nucleoside analogue that inhibits the replication of HBV by acting as a substrate for the reverse transcriptase enzyme, preventing the conversion of viral RNA into DNA. This inhibits viral replication and reduces the viral load.
Dosage and Administration:
- Recommended Dose: The typical dose for adults who are treatment-naive is 0.5 mg once daily. For patients who have previously received treatment with other antiviral medications, the dose may be increased to 1 mg once daily.
- Administration: Take the tablet orally, with or without food. It’s important to take it at the same time each day for consistent results.
Side Effects: Common side effects may include:
- Headache
- Fatigue
- Dizziness
- Nausea
- Potential for lactic acidosis (rare but serious)
Warnings and Precautions:
- Liver Function: Regular monitoring of liver function tests is important, as discontinuation of entecavir may result in an exacerbation of hepatitis.
- Lactic Acidosis: Caution is advised in patients with liver disease or those at risk for lactic acidosis.
- Renal Function: Monitor renal function, particularly in patients with pre-existing kidney conditions.
Contraindications:
- Hypersensitivity to entecavir or any components of the formulation.
- Severe renal impairment may require dose adjustment.
Drug Interactions: Entecavir may interact with other medications, particularly those affecting kidney function or liver metabolism. Patients should inform their healthcare provider about all medications they are taking.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and to adhere to the treatment regimen.
- Discuss the importance of regular follow-up appointments for monitoring liver function and viral load.
- Instruct patients to report any unusual side effects, especially symptoms of liver dysfunction or signs of lactic acidosis (e.g., unusual fatigue, muscle pain).
Baraclude (Entecavir) 0.5 mg Tablets are an effective option for managing chronic hepatitis B infection. Adherence to dosing, regular monitoring for side effects, and patient education are essential for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Entecavir 1 mg ( Zhevavir 1 mg Tablets)
Product Brochure
| Strength | 1 mg |
| Pack Size | 1*10 Tablet |
| Composition | Entecavir 1 mg |
| Treatment | Hronic (Long-Term) Hepatitis B Infection |
| Brand | Zhevavir 1 mg |
| Manufacturer By | Sunrise Farma |
Zhevavir (Entecavir) 1 mg Tablets
Overview: Zhevavir is a brand name for entecavir, an antiviral medication used primarily in the treatment of chronic hepatitis B virus (HBV) infection. It is effective in reducing viral load and improving liver function in patients with HBV.
Indications:
- Chronic Hepatitis B Infection: Indicated for the treatment of chronic hepatitis B virus infection in adults and children over the age of 2 years who have evidence of active viral replication and elevated liver enzymes.
Mechanism of Action: Entecavir is a nucleoside analogue that inhibits HBV replication by incorporating into the viral DNA, thus preventing the virus from multiplying. It specifically targets the reverse transcriptase enzyme involved in the viral replication process.
Dosage and Administration:
- Recommended Dose: The typical dose for adults is 0.5 mg daily for patients who are treatment-naive and 1 mg daily for those who have been previously treated with other antiviral medications.
- Administration: Take the tablet orally, with or without food. It is important to take it at the same time each day to maintain consistent levels in the bloodstream.
Side Effects: Common side effects may include:
- Headache
- Fatigue
- Dizziness
- Nausea
- Potential for lactic acidosis (rare but serious)
Warnings and Precautions:
- Liver Function: Monitor liver function tests regularly, as discontinuation of entecavir may result in an exacerbation of hepatitis.
- Lactic Acidosis: Caution is advised in patients with liver disease or those at risk for lactic acidosis.
- Renal Function: Monitor renal function, especially in patients with pre-existing kidney conditions.
Contraindications:
- Hypersensitivity to entecavir or any components of the formulation.
- Severe renal impairment may require dose adjustment.
Drug Interactions: Entecavir may interact with other medications that affect kidney function or are metabolized by the liver. Patients should inform their healthcare provider about all medications they are taking.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and to maintain adherence to the treatment regimen.
- Discuss the importance of regular follow-up appointments for monitoring liver function and viral load.
- Instruct patients to report any unusual side effects, especially symptoms of liver dysfunction or signs of lactic acidosis (e.g., unusual fatigue, muscle pain).
Zhevavir (Entecavir) 1 mg Tablets are an effective treatment option for managing chronic hepatitis B infection. Adherence to dosing, regular monitoring for side effects, and patient education are crucial for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
Denopsy Teriflunomide 7 Mg Tablets
Product Brochure
| Strength | 7 mg |
| Packaging Size | 2*14 tablets |
| Composition | Teriflunomide 7 mg |
| Brand Name | Denopsy 7 mg |
| Manufacturer | Natco |
| Treatment | Backsliding types of different sclerosis (MS) |
Denopsy contains Teriflunomide, an oral medication used primarily for the treatment of multiple sclerosis (MS). It is classified as a disease-modifying therapy that helps reduce the frequency of relapses and slow the progression of disability in patients with relapsing forms of MS.
Indications for UseDenopsy is indicated for:
- Relapsing Forms of Multiple Sclerosis: To decrease the frequency of clinical relapses and delay the progression of physical disability.
Teriflunomide works by:
- Inhibiting Pyrimidine Synthesis: It selectively inhibits the enzyme dihydroorotate dehydrogenase, which is crucial for the proliferation of activated lymphocytes (a type of white blood cell involved in MS).
- Reducing Inflammation: By limiting the activation of immune cells, it helps reduce inflammation in the central nervous system.
- Dosage: The typical starting dose is 14 mg once daily, but in some cases, a lower dose of 7 mg may be prescribed based on patient tolerance or specific medical considerations.
- Administration: Taken orally, with or without food. Consistency in how it is taken (with food or not) is important for maintaining stable drug levels.
Denopsy is contraindicated in:
- Hypersensitivity: Known allergies to Teriflunomide or any components of the formulation.
- Pregnancy: Should not be used during pregnancy or by women planning to become pregnant due to potential teratogenic effects.
- Hepatotoxicity: Regular monitoring of liver function tests is necessary, as Teriflunomide can cause liver damage.
- Infection Risk: Increased susceptibility to infections; patients should be monitored for signs of infection.
- Blood Pressure: May cause hypertension; blood pressure should be monitored regularly.
Common side effects may include:
- Diarrhea
- Nausea
- Abdominal pain
- Headache
- Rash
Serious adverse effects can include:
- Liver injury (hepatotoxicity)
- Severe infections (due to immunosuppression)
- Blood disorders (like thrombocytopenia)
Teriflunomide may interact with other medications, particularly those that affect liver enzymes or immune function. It’s essential to inform healthcare providers about all medications being taken.
Storage InstructionsStore Denopsy at room temperature, protected from moisture and light. Follow any specific storage guidelines provided on the product label.
Patient Counseling Information- Report Side Effects: Encourage patients to notify their healthcare provider of any unusual symptoms or side effects.
- Regular Monitoring: Stress the importance of regular blood tests to monitor liver function and blood cell counts.
- Contraceptive Measures: Advise women of childbearing age to use effective contraception during treatment and for a period after discontinuation.
Denopsy (Teriflunomide) 7 mg Tablets are an important treatment option for managing relapsing forms of multiple sclerosis. Proper use, monitoring, and patient education are crucial for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare professional for personalized advice and management plans.
Olumiant Baricitinib 2 mg Tablets
Product Brochure
| Strength / Dose | 2 mg |
| Packaging Size | 7 Tablets |
| Composition | Baricitinib 2 mg |
| Brand Name | Olumiant |
| Manufacturer By | Eli Lilly and Company India Pvt Ltd |
| Treatment | Rheumatoid arthritis |
Overview:
Olumiant 2mg Tablet contains Baricitinib, a Janus kinase (JAK) inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other therapies like methotrexate. By inhibiting JAK1 and JAK2, Baricitinib reduces the activity of immune cells responsible for inflammation, helping manage symptoms such as pain, swelling, and joint damage.
Indications:
Olumiant 2mg Tablet is primarily indicated for:
- Rheumatoid Arthritis (RA): To treat moderate to severe RA in adults who have failed or cannot tolerate other disease-modifying antirheumatic drugs (DMARDs).
- Atopic Dermatitis: It may also be used for atopic dermatitis in certain patients based on a healthcare provider's discretion.
Mechanism of Action:
Baricitinib works by inhibiting Janus kinases (JAKs), which are enzymes involved in the inflammatory process. By blocking these enzymes, it reduces the production of pro-inflammatory cytokines, helping to control symptoms and prevent further joint damage in patients with RA.
Dosage and Administration:
- Recommended Dose: 2mg once daily, with or without food. The dose may be increased to 4mg based on the patient's condition and tolerance.
- Administration: Take Orally with water. Do not chew, crush, or break the tablet.
- Adjustments: Adjust the dosage for renal or liver impairment.
Side Effects:
Common side effects include:
- Nausea, headache, high blood pressure, and upper respiratory infections.
- Fatigue, diarrhea, and acne.
Serious side effects may include:
- Infections (e.g., tuberculosis, fungal infections).
- Blood clots and cardiovascular risks (e.g., DVT, PE).
- Liver damage: Regular monitoring is essential.
Precautions:
- Infections: Screen for active infections before starting therapy.
- Pregnancy: Avoid use during pregnancy.
- Liver and Kidney Health: Monitor liver and kidney function regularly.
Storage:
Store at room temperature (20°C to 25°C), away from moisture and heat.
Conclusion:
Olumiant 2mg Tablet (Baricitinib) is an effective treatment for moderate to severe rheumatoid arthritis in adults who have not responded to traditional DMARDs. Careful monitoring for infections, blood clots, liver function, and cardiovascular health is essential for safe use.
Darunavir Tablets (Daruvir 800 mg Tablets)
Product Brochure
| Strength | 800 mg |
| Composition | Darunavir 800 mg |
| Packaging Size | 30 Tablets in 1 Bottle |
| Brand | Daruvir 800 mg Tablets |
| Manufactured by | Cipla Ltd |
| Dose/Strength | 800 mg |
| Treatment | HIV infection |
Daruvir (Darunavir) 800 mg Tablets
Overview: Daruvir is a brand of darunavir, a protease inhibitor used in the treatment of HIV-1 infection. It is often used as part of a combination antiretroviral therapy regimen to reduce viral load and improve immune function.
Indications:
- HIV Infection: Indicated for the treatment of HIV-1 infection in adults and pediatric patients aged 3 years and older, typically in combination with other antiretroviral agents.
Mechanism of Action: Darunavir works by inhibiting the HIV protease enzyme, which is crucial for the maturation and replication of the virus. By blocking this enzyme, darunavir prevents the production of infectious viral particles, thereby reducing the viral load in the body.
Dosage and Administration:
- Recommended Dose: The typical dose for adults is 800 mg taken orally once daily, usually in combination with a low dose of ritonavir (100 mg) or cobicistat (as a booster) to enhance its effectiveness.
- Administration: Take the tablet with food to improve absorption.
Side Effects: Common side effects may include:
- Nausea
- Diarrhea
- Fatigue
- Rash
- Headache
- Elevated liver enzymes
Warnings and Precautions:
- Hepatic Function: Monitor liver function regularly, especially in patients with a history of liver disease.
- Allergic Reactions: Be vigilant for signs of severe skin reactions or hypersensitivity.
- Drug Interactions: Darunavir may interact with other medications, especially those that affect liver enzymes. It is important to inform healthcare providers of all medications being taken.
Contraindications:
- Hypersensitivity to darunavir or any components of the formulation.
- Concomitant use with certain medications that can cause significant interactions.
Drug Interactions: Darunavir may interact with various medications, particularly those metabolized by the CYP450 enzyme system. Patients should discuss all medications and supplements with their healthcare provider to avoid potential interactions.
Storage Instructions: Store at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to take the medication as prescribed and not to miss doses for optimal effectiveness.
- Discuss the importance of regular follow-up appointments for monitoring health and viral load.
- Instruct patients to report any unusual side effects, particularly skin reactions or gastrointestinal symptoms.
Daruvir (Darunavir) 800 mg Tablets are an important part of the treatment regimen for HIV-1 infection. Adherence to dosing, monitoring for side effects, and patient education are essential for achieving optimal treatment outcomes. Always consult a healthcare provider for personalized treatment recommendations.
50mg Trombonat Eltrombopag Olamine Tablet
Product Brochure
| Strength | 50 mg |
| Packaging Type | 4*7 Tablet |
| Composition | Eltrombopag |
| Brand | Trombonat 50mg |
| Manufactured By | Natco Pharma Ltd |
| Treatment | Severe Aplastic Anemia |
Overview: Trombonat contains Eltrombopag Olamine, a thrombopoietin receptor agonist used to treat low platelet counts in patients with certain blood disorders. It works by stimulating the thrombopoietin receptor on bone marrow cells, which promotes the production of platelets (cells responsible for blood clotting). This is particularly useful in conditions like chronic immune thrombocytopenia (ITP) and severe aplastic anemia.
Indications: Trombonat 50mg Tablet is indicated for:
- Chronic Immune Thrombocytopenia (ITP): Treatment of adults and children with ITP who have had an insufficient response to other treatments.
- Severe Aplastic Anemia: For patients with severe aplastic anemia who have not responded to immunosuppressive therapy.
- Chronic Hepatitis C: In combination with other drugs, to increase platelet count in patients undergoing interferon-based therapy.
Mechanism of Action: Eltrombopag binds to and activates the thrombopoietin receptor (TPOR) on hematopoietic stem cells in the bone marrow, leading to increased platelet production. By stimulating the production of platelets, it helps increase blood platelet counts in conditions where platelet production is insufficient.
Dosage and Administration:
- Chronic Immune Thrombocytopenia (ITP): The usual starting dose is 50mg once daily. For patients who do not achieve an adequate response, the dose may be increased to 75mg.
- Severe Aplastic Anemia: The typical dose is 50mg once daily, adjusted based on individual response and tolerability.
- Tablets should be taken once daily, with or without food. Do not crush or chew.
Side Effects: Common side effects include:
- Headache, nausea, and fatigue.
- Liver enzyme abnormalities (e.g., ALT, AST).
- Musculoskeletal pain or dizziness.
Serious side effects may include:
- Hepatotoxicity: Elevated liver enzymes, jaundice, or liver failure. Regular liver function tests are necessary.
- Bone marrow disorders: Eltrombopag may rarely cause bone marrow fibrosis or hematologic malignancies.
- Thromboembolic events: There may be an increased risk of blood clots in certain patients.
Precautions:
- Liver Function: Regular monitoring of liver function (ALT, AST, bilirubin) is required during treatment. Discontinue if significant liver toxicity occurs.
- Pregnancy and Breastfeeding: Use during pregnancy is not recommended due to potential fetal harm. Eltrombopag should be avoided while breastfeeding.
- Drug Interactions: Eltrombopag may interact with drugs that affect liver enzymes (e.g., CYP1A2, CYP2C8), affecting its metabolism. Inform your doctor of all medications being taken.
Storage: Store at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion: Trombonat (Eltrombopag Olamine) 50mg Tablet is an effective treatment for chronic immune thrombocytopenia (ITP) and severe aplastic anemia. By stimulating platelet production in the bone marrow, it helps improve platelet counts and reduce the risk of bleeding. Regular monitoring for liver function and other side effects is essential for safe use.
Bosentan Bosenat 125mg Tablet
Product Brochure
| Dose/Strength | 125 mg |
| Packaging Size | 10*10 tablets |
| Composition | Bosentan 125 mg |
| Manufactured By | Natco |
| Brand Name | Bosenat 125 mg |
| Treatment | Aspiratory Blood Vessel Hypertension (PAH) |
Active Ingredient: Bosentan
Uses:
Bosenat is primarily used for:
- Pulmonary Arterial Hypertension (PAH): To improve exercise ability and decrease the rate of clinical worsening in patients with PAH.
Bosentan is an endothelin receptor antagonist. It works by blocking the effects of endothelin-1, a substance in the blood that causes blood vessels to constrict. By inhibiting this action, Bosentan helps to relax and widen blood vessels, leading to decreased blood pressure in the pulmonary artery.
Dosage and Administration:- Typical Dosage: The usual starting dose is 62.5 mg taken orally twice daily, which may be increased to 125 mg twice daily based on the patient’s response and tolerance.
- Administration: Can be taken with or without food. It’s important to take it consistently at the same times each day.
- Hypersensitivity: Avoid in individuals with known allergies to Bosentan or any components of the formulation.
- Pregnancy: Not recommended during pregnancy due to potential harm to the fetus.
- Liver Function: Monitor liver function tests regularly, as Bosentan can cause liver enzyme elevations.
- Blood Pressure: Patients should be monitored for low blood pressure (hypotension).
- Drug Interactions: Inform healthcare providers of all medications being taken, as Bosentan can interact with other drugs.
- Headache
- Flushing
- Edema (swelling)
- Nasal congestion
- Liver enzyme elevation
- Liver dysfunction (e.g., jaundice, severe fatigue)
- Allergic reactions (e.g., rash, itching, swelling)
- Severe hypotension
Store Bosenat tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects, particularly signs of liver dysfunction.
- Adherence: Emphasize the importance of taking the medication as prescribed and not missing doses.
- Regular Monitoring: Stress the need for regular follow-up appointments for liver function tests and blood pressure monitoring.
Bosenat (Bosentan) 125 mg Tablets are an effective treatment for pulmonary arterial hypertension, helping to improve quality of life and exercise capacity. Proper adherence to the treatment regimen and monitoring for side effects are crucial for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
Levocetirizine Tablets (Levocetzime 10mg Tablets)
Product Brochure
| Strength | 10 mg |
| Packaging Size | 10 tablets in 1 strip |
| Composition | Levocetirizine 10mg |
| Brand | Levocetzime 10mg Tablets |
| Manufactured By | Healing Pharma India Pvt Ltd |
| Usage/Application | Treatment of Allergic conditions |
Overview
Levocetzime contains levocetirizine, an antihistamine used primarily to relieve allergy symptoms. It is an enantiomer of cetirizine and is effective in treating allergic rhinitis and chronic urticaria (hives).
- Allergic Rhinitis: Relief of symptoms such as sneezing, runny or itchy nose, and itchy or watery eyes due to allergies.
- Chronic Urticaria: Treatment of itching and rash associated with chronic hives.
- Antihistamine Activity: Levocetirizine selectively inhibits peripheral H1 receptors, reducing the effects of histamine, a substance in the body that causes allergic symptoms. This action helps alleviate allergic responses.
- Dosage: The usual recommended dose for adults and children over 12 years is 10 mg once daily. For children aged 6 to 11 years, a lower dose may be recommended.
- Administration: Take the tablet orally with or without food, preferably at the same time each day.
Common side effects may include:
- Drowsiness
- Fatigue
- Dry mouth
- Headache
- Drowsiness: May cause drowsiness; caution is advised when driving or operating heavy machinery.
- Kidney Function: Use with caution in patients with renal impairment; dosage adjustments may be necessary.
- Alcohol Interaction: Avoid alcohol, as it can enhance drowsiness.
- Hypersensitivity: Known allergies to levocetirizine, cetirizine, or any components of the formulation.
Levocetirizine may interact with:
- Central Nervous System Depressants: Increased sedation when used with other CNS depressants (e.g., alcohol, sedatives).
- Store Levocetzime at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients about the potential for drowsiness and the need to avoid activities requiring alertness until they know how the medication affects them.
- Advise them to take the medication consistently and report any severe side effects or allergic reactions.
Levocetzime (Levocetirizine 10 mg Tablets) is an effective antihistamine for managing allergy symptoms and chronic urticaria. Proper usage and patient education are essential for optimizing therapeutic benefits and minimizing risks. Always consult a healthcare provider for personalized advice and guidance.
Finerenone Kerendia 20mg Tablet
Product Brochure
| Strength | 20 mg |
| Packaging Type | Strips |
| Packaging Size | 14 tablets in 1 box |
| Brand | Kerendia 20 mg |
| Manufactured By | Bayer Zydus Pharma Pvt Ltd |
| Composition | Finerenone Film Coated Tablets 20 mg |
| Treatment | Chronic kidney disease |
Overview
Kerendia contains finerenone, a non-steroidal mineralocorticoid receptor antagonist (MRA) designed to manage chronic kidney disease (CKD) in patients with type 2 diabetes.
- Chronic Kidney Disease: Used to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular events in adults with CKD associated with type 2 diabetes.
- Mineralocorticoid Receptor Antagonism: Finerenone selectively inhibits mineralocorticoid receptors, leading to reduced inflammation and fibrosis in the kidneys, which can slow CKD progression and improve renal and cardiovascular outcomes.
- Dosage: The typical starting dose is 10 mg once daily, which may be increased to 20 mg once daily based on the patient's renal function and response to treatment.
- Administration: Take the tablet orally, with or without food, preferably at the same time each day.
Common side effects may include:
- Hyperkalemia (high potassium levels)
- Hypotension (low blood pressure)
- Renal impairment
- Electrolyte Monitoring: Regular monitoring of serum potassium levels is essential, especially during treatment initiation and dose adjustments.
- Caution in Renal Impairment: Use with caution in patients with moderate to severe renal impairment.
- Hypotension Risk: Monitor blood pressure, particularly in patients on other antihypertensive medications.
- Hypersensitivity: Known allergies to finerenone or any components of the formulation.
- Severe Hyperkalemia: Contraindicated in patients with significantly elevated potassium levels.
Finerenone may interact with:
- Potassium-Sparing Diuretics: Increased risk of hyperkalemia.
- Certain Antihypertensives: Monitor for additive effects on blood pressure.
- Store Kerendia at room temperature, away from moisture and light. Keep out of reach of children.
- Educate patients on the importance of adhering to the prescribed regimen and attending regular follow-up appointments for monitoring.
- Advise them to report any symptoms of hyperkalemia (e.g., muscle weakness, irregular heartbeat) or signs of hypotension (e.g., dizziness, fainting).
- Encourage a balanced diet with limited potassium intake, if advised by a healthcare provider.
Kerendia (Finerenone 20 mg Tablet) is an important medication for managing chronic kidney disease in patients with type 2 diabetes. Proper monitoring and patient education are essential for maximizing therapeutic benefits while minimizing risks. Always consult a healthcare provider for personalized advice and guidance.
Teriflunomide Denopsy 14mg Tablets
Product Brochure
| Strength | 14 mg |
| Packaging Size | 3*10 tablets |
| Composition | Teriflunomide |
| Brand Name | Denopsy 14 mg |
| Manufacturer | Natco |
| Treatment | Backsliding types of different sclerosis (MS) |
Denopsy contains Teriflunomide, an oral medication used for the treatment of relapsing forms of multiple sclerosis (MS). It is classified as a disease-modifying therapy aimed at reducing the frequency of relapses and slowing disease progression.
Indications for UseDenopsy is indicated for:
- Relapsing Forms of Multiple Sclerosis: To decrease the frequency of clinical relapses and delay the progression of disability in patients with MS.
Teriflunomide works by:
- Inhibiting Pyrimidine Synthesis: It selectively inhibits dihydroorotate dehydrogenase, an enzyme crucial for the proliferation of activated lymphocytes (a type of white blood cell involved in MS).
- Reducing Inflammation: By limiting the activation of immune cells, it helps decrease inflammation in the central nervous system.
- Dosage: The standard dose is typically 14 mg once daily. This can be adjusted based on individual patient needs and tolerability.
- Administration: Taken orally, with or without food. Consistency in taking it with or without food is important for maintaining stable drug levels.
Denopsy is contraindicated in:
- Hypersensitivity: Known allergies to Teriflunomide or any components of the formulation.
- Pregnancy: Should not be used during pregnancy or by women planning to become pregnant due to potential teratogenic effects.
- Hepatotoxicity: Liver function tests should be monitored regularly, as Teriflunomide can cause liver damage.
- Infection Risk: Increased susceptibility to infections due to immunosuppression; patients should be monitored for signs of infection.
- Hypertension: May cause increased blood pressure; regular monitoring is advised.
Common side effects may include:
- Diarrhea
- Nausea
- Abdominal pain
- Headache
- Rash
Serious adverse effects can include:
- Severe liver injury (hepatotoxicity)
- Serious infections
- Blood disorders, such as thrombocytopenia
Teriflunomide may interact with other medications, particularly those that affect liver enzymes or the immune system. Patients should inform their healthcare provider about all medications and supplements they are taking.
Storage InstructionsStore Denopsy at room temperature, away from moisture and light. Follow any specific storage guidelines provided on the product label.
Patient Counseling Information- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects.
- Regular Monitoring: Emphasize the importance of regular blood tests to monitor liver function and blood cell counts.
- Contraceptive Measures: Women of childbearing age should use effective contraception during treatment and for a period after discontinuation.
Denopsy (Teriflunomide) 14 mg Tablets are an effective option for managing relapsing forms of multiple sclerosis. Proper usage, monitoring, and patient education are crucial for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare professional for personalized advice and management plans.
Bosentas 125 Mg Tablet
Product Brochure
| Dose/Strength | 125 mg |
| Manufactured By | Cipla Ltd |
| Pack Size | 10 Tablet |
| Composition (Salt) | Bosentan 125 mg |
| Brand Name | Bosentas 125 Mg |
| Treatment | Pulmonary Arterial Hypertension (PAH) |
Active Ingredient: Bosentan
Uses:
Bosentas is primarily indicated for:
- Pulmonary Arterial Hypertension (PAH): Used to improve exercise ability and reduce the rate of clinical worsening in patients with PAH.
Bosentan is an endothelin receptor antagonist. It blocks the effects of endothelin-1, a substance that causes blood vessels to constrict. By inhibiting this action, Bosentan helps to relax and widen blood vessels, thereby reducing blood pressure in the pulmonary arteries.
Dosage and Administration:- Typical Dosage: The usual starting dose is 62.5 mg taken orally twice daily, which may be increased to 125 mg twice daily based on individual response and tolerance.
- Administration: Can be taken with or without food. It’s important to take it consistently at the same times each day.
- Hypersensitivity: Avoid in individuals with known allergies to Bosentan or any of its components.
- Pregnancy: Not recommended for use during pregnancy due to potential risks to the fetus.
- Liver Function: Regular monitoring of liver function tests is necessary, as Bosentan can cause liver enzyme elevations.
- Blood Pressure: Monitor for hypotension (low blood pressure) in patients.
- Drug Interactions: Inform healthcare providers of all medications being taken, as Bosentan can interact with several other drugs.
- Headache
- Flushing
- Swelling (edema)
- Nasal congestion
- Liver enzyme elevation
- Liver dysfunction (e.g., jaundice, severe fatigue)
- Allergic reactions (e.g., rash, swelling)
- Severe hypotension
Store Bosentas tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects, especially signs of liver dysfunction.
- Adherence: Emphasize the importance of taking the medication as prescribed and not missing doses.
- Regular Monitoring: Stress the need for regular follow-up appointments for liver function tests and blood pressure monitoring.
Bosentas (Bosentan) 125 mg Tablets are effective in treating pulmonary arterial hypertension, helping to improve patients' quality of life. Proper adherence to the treatment regimen and monitoring for side effects are crucial for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
Cilostaheal Cilostazol 50mg Tablets
Product Brochure
| Strength | 50 mg |
| Pack Size | 1*10 Tablet |
| Composition | Cilostazol 50mg |
| Brand | Cilostaheal 50 mg Tablets |
| Manufactured By | Healing Pharma India Pvt Ltd |
| Treatment | Intermittent Claudication |
Active Ingredient: Cilostazol
Uses:
Cilostaheal is primarily used for:
- Intermittent Claudication: To improve walking distance in patients with this condition, which is caused by poor blood flow to the legs.
Cilostazol works by inhibiting phosphodiesterase type 3 (PDE3), which leads to increased levels of cyclic AMP (cAMP) in platelets and blood vessels. This results in vasodilation (widening of blood vessels) and inhibition of platelet aggregation, improving blood flow and reducing symptoms of claudication.
Dosage and Administration:- Typical Dosage: The usual dose is 100 mg taken orally twice daily. However, it may be initiated at 50 mg twice daily in some cases.
- Administration: Take the tablets at least half an hour before or two hours after meals for optimal absorption.
- Hypersensitivity: Avoid in individuals with known allergies to Cilostazol or any components of the formulation.
- Heart Failure: Not recommended in patients with congestive heart failure (CHF) of any severity.
- Bleeding Risk: Caution in patients with bleeding disorders or those taking anticoagulant or antiplatelet medications.
- Liver Function: Monitor liver function, as Cilostazol is metabolized in the liver.
- Drug Interactions: Inform healthcare providers about all medications being taken, as Cilostazol can interact with other drugs.
- Headache
- Diarrhea
- Dizziness
- Palpitations
- Flushing
- Severe headache
- Abnormal bleeding or bruising
- Symptoms of heart failure (e.g., shortness of breath, swelling)
Store Cilostaheal tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects, particularly severe headaches or signs of bleeding.
- Adherence: Emphasize the importance of taking the medication as prescribed and not missing doses.
- Lifestyle Modifications: Encourage patients to engage in supervised exercise programs to improve walking ability.
Cilostaheal (Cilostazol) 50 mg Tablets are effective in improving walking distance for patients with intermittent claudication. Proper adherence to the treatment regimen and monitoring for side effects are essential for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
Immulina Pidotimod 800mg Tablets
Product Brochure
| Strength | 800 mg |
| Packaging Size | 1 box of 10 tablets |
| Composition | Pidotimod 800 mg |
| Brand Name | Immulina 800mg |
| Manufactured By | Mr. Reddy's |
| Usage/Application | Diseases of respiratory tract |
Active Ingredient: Pidotimod
Uses:
Immulina is primarily used for:
- Immune System Support: It is indicated for the prevention and treatment of recurrent respiratory infections, particularly in children.
- Adjunct Therapy: Often used alongside conventional treatments for infections to enhance immune response.
Pidotimod acts as an immunomodulator. It stimulates the immune system by enhancing the activity of macrophages and T-cells, promoting a more effective immune response against pathogens. This helps in reducing the frequency and severity of infections.
Dosage and Administration:- Typical Dosage: The usual dose for adults and children may vary, but commonly it is taken as 800 mg once daily. The specific dosage should be determined by a healthcare provider based on the condition being treated.
- Administration: Can be taken with or without food. It’s advisable to take the tablet whole with water.
- Hypersensitivity: Avoid in individuals with known allergies to Pidotimod or any components of the formulation.
- Pregnancy and Breastfeeding: Consult a healthcare provider before use during pregnancy or while breastfeeding.
- Autoimmune Disorders: Use with caution in patients with autoimmune conditions.
- Nausea
- Diarrhea
- Abdominal pain
- Headache
- Mild allergic reactions (e.g., rash)
- Severe allergic reactions (e.g., difficulty breathing, swelling of the face or throat)
- Signs of infection (fever, persistent cough)
Store Immulina tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects.
- Adherence: Emphasize the importance of taking the medication as prescribed and completing the full course of treatment, especially for recurrent infections.
Immulina (Pidotimod) 800 mg Tablets are effective for enhancing immune response and reducing the frequency of respiratory infections. Proper adherence to the treatment regimen and monitoring for side effects are crucial for safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
P-Zide Pyrazinamide 1000mg Tablet
Product Brochure
| Strength | 1000 mg |
| Packaging Size | 10*10 Tablets |
| Composition | Pyrazinamide |
| Brand Name | P Zide 1000 mg |
| Manufactured By | Cadila 1000 mg |
| Usage/Application | Medical |
Active Ingredient: Pyrazinamide
Uses:
P-Zide is primarily used for:
- Tuberculosis Treatment: It is part of a multi-drug regimen for the treatment of active tuberculosis (TB), especially during the initial phase of therapy.
Pyrazinamide works by inhibiting the growth of Mycobacterium tuberculosis, the bacterium responsible for TB. It is believed to disrupt mycobacterial cell metabolism and energy production, contributing to bacterial death.
Dosage and Administration:- Typical Dosage: The usual dose for adults is 25 mg/kg (up to 1000 mg) taken orally once daily. The specific dosage may vary based on the patient's weight and healthcare provider's recommendations.
- Administration: Can be taken with or without food. Consistent dosing at the same time each day is recommended for optimal efficacy.
- Hypersensitivity: Avoid in individuals with known allergies to Pyrazinamide or any components of the formulation.
- Severe Liver Disease: Caution is advised in patients with liver impairment; liver function tests may be necessary.
- Liver Function: Regular monitoring of liver function is essential, as Pyrazinamide can cause hepatotoxicity.
- Gout: Can increase uric acid levels; caution is needed in patients with a history of gout.
- Drug Interactions: Inform healthcare providers about all medications being taken, as Pyrazinamide may interact with other drugs.
- Nausea
- Vomiting
- Loss of appetite
- Fatigue
- Joint pain
- Liver dysfunction (e.g., jaundice, elevated liver enzymes)
- Allergic reactions (e.g., rash, itching)
- Severe gastrointestinal symptoms
Store P-Zide tablets at room temperature, away from moisture and light. Follow any specific storage guidelines provided with the product.
Patient Counseling Information:- Report Side Effects: Advise patients to notify their healthcare provider of any unusual symptoms or side effects, especially signs of liver problems.
- Adherence: Emphasize the importance of completing the full course of treatment as prescribed, even if symptoms improve.
- Hydration: Encourage patients to stay well-hydrated and maintain a healthy diet during treatment.
P-Zide (Pyrazinamide) 1000 mg Tablets are a crucial component in the treatment of tuberculosis. Proper adherence to the treatment regimen and monitoring for side effects are essential for ensuring safety and effectiveness. Always consult a healthcare professional for personalized guidance regarding this medication.
View More